About the Company
We do not have any company description for Allena Pharmaceuticals Inc at the moment.
Please visit http://www.allenapharma.com/ for more information about the company.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ALNA News
Allena Pharmaceuticals (NASDAQ: ALNA)
Allena Pharmaceuticals, Inc. engages in the development, discovery, and commercialization of oral enzyme therapeutics to treat patients with kidney disorders. Its product pipeline includes ...
Allena Pharmaceuticals Inc. (ALNAQ)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...
Allena Pharmaceuticals (ALNA) Enters Overbought Territory
Allena Pharmaceuticals, Inc. ALNA has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because ALNA is now in overbought territory with an ...
Allena Pharma (ALNAQ) Earnings Dates & Reports
View upcoming earnings forecasts and in-depth analysis of company forecasts.
CNFinance Hldgs Stock (NYSE:CNF), Quotes and News Summary
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after ...
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...
Frazier Healthcare VI, L.P.'s Net Worth
Who is Frazier Healthcare VI, L.P.? Frazier Healthcare VI, L.P. has an estimated net worth of $132 Million. This is based on reported shares across multiple companies, which include COLLEGIUM ...
Amylyx Pharmaceuticals Inc AMLX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Vertex Pharmaceuticals Inc VRTX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
SNOA Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the ...
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates
Mirum Pharmaceuticals, Inc. (MIRM) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.99 per share a year ago.
Loading the latest forecasts...